Abstract:A tailor‐made photosensitizer based on boron dipyrromethene conjugated with a galactose moiety through a self‐immolative linker has been designed and synthesized. It exhibits a selective response toward the senescence‐associated β‐galactosidase, rendering it an efficient theranostic behavior for detection and photodynamic elimination of senescent cells in vitro and in vivo. Senescence is a cellular response having physiological and reparative functions to preserve tissue homeostasis and suppress tumor growth. However, the accumulation of senescent cells would cause deleterious effects that lead to age‐related dysfunctions and cancer progression. Hence, selective detection and elimination of senescent cells are crucial yet remain a challenge. A β‐galactosidase (β‐gal)‐activated boron dipyrromethene (BODIPY)‐based photosensitizer (compound 1) is reported here that can selectively detect and eradicate senescent cells. It contains a galactose moiety connected to a pyridinium BODIPY via a self‐immolative nitrophenylene linker, of which the photoactivity is effectively quenched. Upon interactions with the senescence‐associated β‐gal, it undergoes enzymatic hydrolysis followed by self‐immolation, leading to the release of an activated BODIPY moiety by which the fluorescence emission and singlet oxygen generation are restored. The ability of 1 to detect and eliminate senescent cells is demonstrated in vitro and in vivo, using SK‐Mel‐103 tumor‐bearing mice treated with senescence‐inducing therapy. The results demonstrate that 1 can be selectively activated in senescent cells to trigger a robust senolytic effect upon irradiation. This study breaks new ground in the design and application of new senolytic agents based on photodynamic therapy.

β-galactosidase responsive AIE fluorogene for identification and removal of senescent cancer cells

An Activatable NIR Probe for the Detection and Elimination of Senescent Cells

A Tutor Agent for supporting distributed knowledge modelling in interactive product design

Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker

Detection and Elimination of Senescent Cells with a Self-Assembled Senescence-Associated β-Galactosidase-Activatable Nanophotosensitizer

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation

Redox-responsive Fluorescent AIE Bioconjugate with Aggregation Enhanced Retention Features for Targeted Imaging Reinforcement and Selective Suppression of Cancer Cells

β‐Galactosidase‐Triggered Photodynamic Elimination of Senescent Cells with a Boron Dipyrromethene‐Based Photosensitizer

A Chalcone-based ESIPT and AIE Fluorophore for β-galactosidase Imaging in Living Cells

Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice

A renal clearable fluorogenic probe for in vivo β-galactosidase activity detection during aging and senolysis

A Tandemly Activated Fluorescence Probe for Detecting Senescent Cells with Improved Selectivity by Targeting a Biomarker Combination.

[Weaning off artificial ventilation].

Senolytic Therapy Enabled by Senescent Cell‐Sensitive Biomimetic Melanin Nano‐senolytics

A Mitochondria-targeted AIEgen Labelled with <SUP>18</SUP>F for Breast Cancer Cell Imaging and Therapy

A rationally designed fluorescence probe achieves highly specific and long‐term detection of senescence in vitro and in vivo

Photoactivatable senolysis with single-cell resolution delays aging

A rapid-response near-infrared fluorescent probe with a large Stokes shift for senescence-associated β-galactosidase activity detection and imaging of senescent cells

A β-galactosidase kiss of death for senescent cells